Facility Design and Engineering

Mar 22, 2018
By BioPharm International Editors
The company plans to install 4000-L disposable bioreactors from ABEC at its new commercial manufacturing facility in Wuxi city, China.
Mar 20, 2018
By BioPharm International Editors
ISPE announced BioMarin Pharmaceutical, Shire, Vetter, and Wyeth Pharmaceuticals as FOYA Category winners.
Mar 15, 2018
BioPharm International
A different perspective on controlling fixed costs of biomanufacturing, based on know-how from other industries, provides a competitive edge, says the CEO of Samsung BioLogics.
Mar 05, 2018
By BioPharm International Editors
JLL, a real estate and investment management firm, recently released a new report on three trends shaping labs for the future of life sciences R&D.
Feb 23, 2018
By BioPharm International Editors
The contract development and manufacturing organization has entered it first manufacturing contract worth $148 million for its recently completed Plant 3 facility.
Feb 22, 2018
By BioPharm International Editors
The new training center, the Jefferson Institute for Bioprocessing, will prepare engineering students and industry professionals for the field of biologics manufacturing.
Feb 06, 2018
By BioPharm International Editors
Amgen plans to invest approximately $300 million in a new biomanufacturing plant in the United States.
Feb 01, 2018
BioPharm International
BioPharm International asked Andrew Bulpin, head of Process Solutions at MilliporeSigma, about the end-of-life options for disposable components of biopharmaceutical single-use systems.
Feb 01, 2018
BioPharm International
Single-use technologies are starting to gain ground as capacity needs change, but industrywide adoption remains low.
Feb 01, 2018
BioPharm International
Layout and supply details must be considered when implementing a fully disposable biopharmaceutical manufacturing process.
native1_300x100
lorem ipsum